PDCD1 and cancer: We have previously shown that activation of cancer cell-intrinsic IFN response is crucial for induction of adaptive cytotoxic anti-tumour immune programmes and long-term responses induced by KRASG12C inhibition, especially in combination with anti-PD-1 therapies24.